A/Prof Jim Jackson is an experienced, supportive radiation oncologist who is committed to delivering prompt, personalised cancer treatment for those in his care. He is passionate about cutting-edge radiation therapy and maintains an active involvement in clinical research to deliver the best possible outcome for his patients.
A/Prof Jim Jackson is an experienced radiation oncologist at Icon Cancer Centre Gold Coast, Icon Cancer Centre North Lakes and Icon Cancer Centre Greenslopes. He completed his medical degree (MBBS) at the University of Queensland in 2004. Prior to this A/Prof Jackson had completed a Bachelor of Arts in Psychology at the University of California, Los Angeles (UCLA) and is currently a PhD candidate at Monash University, where he is investigating methods to reduce side effects of cancer treatment.
A/Prof Jackson completed his radiation oncology training in Queensland and in 2012, he undertook a clinical research fellowship at the Austin-Olivia Newton-John Cancer and Wellness Centre in Image Guided and Intensity Modulated Radiation Therapy (IMRT). In January 2014, he joined Icon Cancer Centre Gold Coast bringing his expertise in providing state-of-the-art treatment techniques including stereotactic radiation therapy for lung and brain tumours.
A/Prof Jackson has special interests in brain, head and neck, gynaecological, genitourinary, lung, skin and breast cancers. He enjoys teaching medical students and is a research supervisor for radiation oncology trainees and university students. He holds appointments as Honorary Adjunct Assistant Professor at Bond University and Senior Lecturer in Medicine at Griffith University.
He is a member of the Icon Cancer Centre Research Committee and has held several roles with the Royal Australia and New Zealand College of Radiologists (RANZCR), at a national level. In October 2016, he served as scientific co-convenor for the RANZCR Annual Scientific Meeting, at the Gold Coast Exhibition and Convention Centre. He is a member of both the American and European Radiation Oncology Societies and regularly reviews scientific papers for national and international medical journals.